From a mechanistic point of view, Harms and Chen 11 demonstrated that HDAC2 gene silencing inhibits cellular proliferation of breast cancer MCF‐7 cells bearing wild‐type p53 through the activation of p53. The gene discussed is HDAC2; the disease is breast cancer.